Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „event“
Suchtreffer
Begriffe & Kennungen
Adtralza · 4.8 · 7 The rate of injection site reactions in the initial 16 weeks treatment period was 51.5 events/100 patient ye
Eintrag öffnenAdtralza · 4.8 · Conjunctivitis and related events Conjunctivitis occurred more frequently in atopic dermatitis patients who re
Eintrag öffnenAdvagraf · 4.8 · Vascular disorders very common: hypertension common: thromboembolic and ischaemic events, vascular hypotensive
Eintrag öffnenAdynovi · 4.8 · Two events of hypersensitivity were observed. One event was a mild transient non-serious rash, occurring in a
Eintrag öffnenAdynovi · 4.8 · Two events of hypersensitivity were observed. One event was a mild transient non-serious rash, occurring in a
Eintrag öffnenAerius · 4.8 · In a clinical trial with 578 adolescent patients, 12 through 17 years of age, the most common adverse event wa
Eintrag öffnenAerius · 4.8 · In a clinical trial with 578 adolescent patients, 12 through 17 years of age, the most common adverse event wa
Eintrag öffnenAfqlir · 4.8 · A low incidence rate of arterial thromboembolic events was observed in the aflibercept clinical trials in pati
Eintrag öffnenAfqlir · 4.8 · A low incidence rate of arterial thromboembolic events was observed in the aflibercept clinical trials in pati
Eintrag öffnenAfqlir · 4.8 · Arterial thromboembolic events (ATEs) are adverse events potentially related to systemic VEGF inhibition. Ther
Eintrag öffnenAfqlir · 4.8 · Arterial thromboembolic events (ATEs) are adverse events potentially related to systemic VEGF inhibition. Ther
Eintrag öffnenAhzantive · 4.8 · A low incidence rate of arterial thromboembolic events was observed in the aflibercept clinical trials in pati
Eintrag öffnenAhzantive · 4.8 · A low incidence rate of arterial thromboembolic events was observed in the aflibercept clinical trials in pati
Eintrag öffnenAhzantive · 4.8 · Arterial thromboembolic events (ATEs) are adverse events potentially related to systemic VEGF inhibition. Ther
Eintrag öffnenAhzantive · 4.8 · Arterial thromboembolic events (ATEs) are adverse events potentially related to systemic VEGF inhibition. Ther
Eintrag öffnenAkeega · 4.8 · 13 Cardiac events The incidence of treatment-emergent adverse events (TEAEs) of cardiac disorder (all grades)
Eintrag öffnenAkeega · 4.8 · Anaemia Anaemia was the most frequent adverse reaction (51.9%) and most commonly observed Grade 3-4 event (29.
Eintrag öffnenAldara · 4.8 · In trials with 5 times per week dosing 58% of patients experienced at least one adverse event. The most freque
Eintrag öffnenAldara · 4.8 · b) Tabular Listing of adverse events:
Eintrag öffnenAldara · 4.8 · c) Frequently occurring adverse events:
Eintrag öffnen